The therapeutic effect of Picroside II in renal ischemia-reperfusion induced acute kidney injury: An experimental study
Authors:
- Ling RenLRLing Ren
- Lianhua ZhuLZLianhua Zhu
- Yukun LuoYLYukun Luo
- 5 February 2024
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 967, 176391
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82001817)
- National Natural Science Foundation of China (81971635)
- National Natural Science Foundation of China (4143529)
This publication has 25 references indexed in Scilit:
- Acute kidney injuryIntensive Care Medicine, 2023
- Monitoring of renal perfusionIntensive Care Medicine, 2022
- Renal Nano-drug delivery for acute kidney Injury: Current status and future perspectivesJournal of Controlled Release, 2022
- Quantitative Evaluation of Renal Cortex Perfusion Using Contrast-Enhanced Ultrasound Imaging Parameters in Ischemia–Reperfusion Injury in RabbitsUltrasound in Medicine & Biology, 2021
- Application of nanotechnology in acute kidney injury: From diagnosis to therapeutic implicationsJournal of Controlled Release, 2021
- The beneficial pharmacological effects and potential mechanisms of picroside II: Evidence of its benefits from in vitro and in vivoBiomedicine & Pharmacotherapy, 2020
- Nose to brain drug delivery - A promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusionPharmacological Research, 2020
- Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptorPhytomedicine, 2020
- Acute kidney injury overview: From basic findings to new prevention and therapy strategiesPharmacology & Therapeutics, 2019
- Disparate outcomes observed within Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury stage 1Kidney International, 2019